Drug Trial Radar · NCT02819284
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
Last checked: Nov 19, 2026Latest source record: Jan 5, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
909
Actual
Start
Jun 2016
Primary completion
Sep 2017
Study completion Sep 2017
Sponsor
- Lead sponsor
- Kala Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jun 30, 2016
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary purpose of this study is to determine the efficacy and safety of KPI-121 0.25% ophthalmic suspension compared to vehicle (placebo) in subjects who have a documented clinical diagnosis of dry eye disease. The product will be studied over 14 days, with 1-2 drops instilled in each eye four times daily (QID).
Conditions
- Dry Eye Syndromes
- Keratoconjunctivitis Sicca
Interventions
KPI-121 0.25% Ophthalmic SuspensionDrug
Vehicle of KPI-121 0.25% Ophthalmic SuspensionDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline/Visit 2 (Day 1) in Bulbar Conjunctival Hyperemia at Visit 4 (Day 15)Time frame: Baseline/Visit 2 (Day 1) - Visit 4 (Day 15)
- Change From Baseline/Visit 2 (Day 1) in Ocular Discomfort Severity at Visit 4 (Day 15)Time frame: Baseline/Visit 2 (Day 1) - Visit 4 (Day 15)
Locations
62 sites in 1 country. Site status is shown where the registry gives one.
UAB School of Optometry
Birmingham, Alabama
Arizona Eye Center
Chandler, Arizona
NEA Baptist Clinic
Jonesboro, Arkansas
Sall Research Medical Center
Artesia, California
Milton M. Hom, OD, FAAO
Azusa, California
Family Eye Care Center
Campbell, California
Orange County Ophthalmology
Garden Grove, California
Lugene Eye Institute
Glendale, California
The Gavin Herbert Eye Institute
Irvine, California
Macy Eye Center
Los Angeles, California
Advanced Vision Care
Los Angeles, California
North Valley Eye Medical Group
Mission Hills, California
Eye Research Foundation
Newport Beach, California
Arch Health Partners
Poway, California
Martel Eye Medical Group
Rancho Cordova, California
Shasta Eye Medical Group, Inc
Redding, California
West Coast Eye Care Associates
San Diego, California
Wolstan & Goldberg Eye Associates
Torrance, California
Michael K Tran, M.D., Inc.
Westminster, California
Hernando Eye Institute
Brooksville, Florida
Central Florida Eye Associates
Lakeland, Florida
Shettle Eye Research, Inc
Largo, Florida
International Eye Associates PA
Ormond Beach, Florida
Perez Eye Center/International Research Center
Tampa, Florida
Eye Care Centers Management, Inc. (Clayton Eye Center)
Morrow, Georgia
Chicago Cornea Consultants, Ltd.
Hoffman Estates, Illinois
Price Vision Group
Indianapolis, Indiana
John-Kenyon American Eye Institute
New Albany, Indiana
Cincinnati Eye Institute
Edgewood, Kentucky
Koffler Vision Group
Lexington, Kentucky
The Eye Care Institute
Louisville, Kentucky
Taustine Eye Center
Louisville, Kentucky
Ophthalmic Consultants of Boston
Boston, Massachusetts
Minnesota Eye Consultants, PA
Bloomington, Minnesota
Tauber Eye Center
Kansas City, Missouri
Tekwani Vision Center
St Louis, Missouri
Comprehensive Eye Care, Ltd. / Vision Research Institute, LLC
Washington, Missouri
Abrams Eye Institute
Las Vegas, Nevada
Raymond Fong, MDPC
New York, New York
Ophthalmic Consultants of Long Island
Rockville Centre, New York
Showing 40 of 62 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.